Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Lupin – Recall of quinapril
December 21, 2022 - The FDA announced a consumer level recall of four lots of Lupin’s quinapril tablets due to the presence of a nitrosamine impurity, N-Nitroso-Quinapril, above the acceptable daily intake level.
